Extracellular Vesicles and Lipid Nanoparticles in Cardiovascular Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 62
Special Issue Editor
2. Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill & Raleigh, NC, USA
Interests: regenerative medicine; biomaterials; drug delivery; extracellular vesicles
Special Issue Information
Dear Colleagues,
In the dynamic landscape of cardiovascular medicine, where advances coexist with persistent challenges, cardiovascular diseases (CVDs) present a formidable global health concern. This Special Issue encourages authors to develop innovative solutions by concurrently exploring extracellular vesicles and lipid nanoparticles. Extracellular vesicles (EVs) have recently emerged as pivotal mediators in intercellular communication during cardiovascular development and pathophysiology, with exosomal non-coding RNAs offering promise as diagnostic and prognostic biomarkers for CVDs. Simultaneously, lipid nanoparticles (LNPs) present themselves as versatile carriers, offering potential solutions for targeted drug delivery in cardiovascular therapies. Stem cell-derived exosomes, with their biocompatibility and non-immunogenicity, and lipid nanoparticles, with their unique drug delivery capabilities, collectively form a compelling narrative for transformative cardiovascular interventions. This Research Topic seeks original research and review articles, offering to provide a platform to research navigating challenges such as EV/LNP manufacturing, RNA-loaded EVs/LNPs, and targeted delivery. Authors are encouraged to delve into diverse themes, from the differentiation of cardiovascular cells to diagnostic innovations and cardiovascular homeostasis, fostering a comprehensive understanding of both extracellular vesicles and lipid nanoparticles in the context of cardiovascular translational medicine.
Dr. Junlang Li
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- exosomes: lipid nanoparticles
- cardiovascular diseases
- RNA delivery
